Hereditary cancer: Theme and variations

Journal of Clinical Oncology

Volumn 15, Issue 10, 1997, Pages 3280-3287

  Knudson, Alfred G ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; DNA REPAIR; FAMILIAL CANCER; GENE MAPPING; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; INHERITANCE; PRIORITY JOURNAL; PROTO ONCOGENE; RISK FACTOR; ARTICLE; DISEASE PREDISPOSITION; GENETICS; MUTATION; NEOPLASM; PEDIGREE; PENETRANCE; TUMOR SUPPRESSOR GENE;

DISEASE SUSCEPTIBILITY; DNA REPAIR; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HUMANS; MUTATION; NEOPLASMS; PEDIGREE; PENETRANCE; PROTO-ONCOGENES;

EID: 0030923394     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1997.15.10.3280     Document Type: Conference Paper

References (31)

1. Knudson AG: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437-1443, 1985
2. Eng C, Clayton D, Schuffenecker I, et al: The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET mutation consortium analysis. JAMA 276:1575-1580, 1996
3. Struewing JP, Abeliovich D, Peretz T, et al: The carrier frequency of the BRCA1 185del AG mutation is approximately 1% in Ashkenazi Jewish individuals. Nature Genet 11:198-200, 1995
4. Hakem R, de la Pompa JL, Sirard C, et al: The tumor suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse. Cell 85:1009-1023, 1996
5. Knudson AG: Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823, 1971
6. Hethcote HW, Knudson AG: Model for the incidence of embryonal cancers: Application to retinoblastoma. Proc Natl Acad Sci USA 75:2453-2457, 1978
7. Knudson AG: Mutation and human cancer. Adv Cancer Res 17:317-352, 1973
8. Knudson AG, Meadows AT, Nichols WW, et al: Chromosomal deletion and retinoblastoma. N Engl J Med 295:1120-1123, 1976
9. Friend SH, Bernards R, Rogelj S, et al: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646, 1986
10. Knudson AG: Retinoblastoma: A prototypic hereditary neoplasm. Semin Oncol 5:57-66, 1978
11. Cavenee WK, Dryja TP, Phillips RA, et al: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779-784, 1983
12. Knudson AG: Model hereditary cancers of man. Prog Nucleic Acid Res Mol Biol 29:17-25, 1983
13. Klein G: The approaching era of the tumor suppressor genes. Science 238:1539-1545, 1987
14. Levy DB, Smith KJ, Beazer-Barclay Y, et al: Inactivation of both APC alleles in human and mouse tumors. Cancer Res 54:5953-5958, 1994
15. Gnarra JR: Mutations of the VHL tumor suppressor gene in renal carcinoma. Nature Genet 7:85-90, 1996
16. Gailani MR, Ståhle-Bäckdahl M, Leffell DJ, et al: The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nature Genet 14:78-81, 1996
17. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87:159-170, 1996
18. Kikuchi-Yanoshita R, Konishi M, Ito S, et al: Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis. Cancer Res 52:3965-3971, 1992
19. Knudson AG: Stem cell regulation, tissue ontogeny, and oncogenic events. Semin Cancer Biol 3:99-106, 1992
20. Naylor SL, Johnson BE, Minna JD, et al: Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 329:451-454, 1987
21. Mulligan LM, Kwok JBJ, Healey CS, et al: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460, 1993
22. Donis-Keller H, Dou S, Chi D, et al: Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2:851-856, 1993
23. Schmidt L, Duh F-M, Chen F, et al: Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nature Genet 16:68-73, 1997
24. INK4a binding domain of CDK4 in familial melanoma. Nature Genet 12:97-99, 1996
25. Savitsky K, Bar-Shira A, Gilad S, et al: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753, 1995
26. Swift M, Morrell D, Massey RB, et al: Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831-1836, 1991
27. Fishel R, Lescoe MK, Rao MR, et al: The human mutator gene homolog MSH2 and its association with hereditary non-polyposis colon cancer. Cell 75:1027-1038, 1993
28. Leach FS, Nicolaides NC, Papadopoulos N, et al: Mutations of a mutS homolog in hereditary non-polyposis colorectal cancer. Cell 75:1215-1225, 1993
29. Bhattacharyya NP, Skandalis A, Ganesh A, et al: Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci USA 91:6319-6323, 1994
30. Scully R, Chen J, Plug A, et al: Association of BRCA1 with Rad 51 in mitotic and meiotic cells. Cell 88:265-275, 1997
31. Sharan SK, Morimatsu M, Albrecht U, et al: Embryonic lethality and radiation hypersensitivity mediated by Rad 51 in mice lacking Brca2. Nature 386:804-810, 1997